Citius Oncology Growth Metrics (2023-2026) | CTOR

Growth Metrics Mar2023 Jun2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin (QoQ) (Quarter) -158300.00
EBIT Margin (QoQ) (Quarter) -158300.00
EBT Margin (QoQ) (Quarter) -147623.00
Enterprise Value Growth (1y) (Quarter) 88.68%72.31%99.66%99.66%-3,504,282.14%-6,513,695.54%-2,350,466.07%
Enterprise Value Growth (3y) (Quarter) -193.29%-179.65%
Enterprise Value (QoQ) (Quarter) 58.37%-207.45%-1.78%0.00%0.00%0.00%-3,504,282.14%-85.88%63.91%
FCF Margin (QoQ) (Quarter) -4333.00
Gross Margin (QoQ) (Quarter) 28.00
Interest Coverage Ratio Growth (1y) (Quarter) 90.92%-5,466.60%99.93%98.84%98.31%
Interest Coverage Ratio (QoQ) (Quarter) -78,731.75%97.05%-3,353.11%-1,708.17%99.96%-43,281.74%99.66%-2,533.13%
Net Margin (QoQ) (Quarter) -145566.00
Operating Margin (QoQ) (Quarter) -158300.00
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) -4731.00-5801.00-4228.002,022.00-2553.00
Return on Capital Employed (QoQ) (Quarter) -26.00-3250.00-1096.00-1677.003,456.001,338.00-5671.00
Return on Sales (QoQ) (Quarter) -15.00